Literature DB >> 29709419

BIOACTIVE GLASS S53P4: a new opportunity for the treatment in the diabetic foot osteomyelitis.

R De Giglio1, I Stefani1, T Mondello1, G De Filippis2, A Mazzone3.   

Abstract

Entities:  

Keywords:  Diabetes; Diabetic foot; Internal medicine

Mesh：

Substances：

Year:  2018        PMID： 29709419     DOI： 10.1016/j.ejim.2018.04.015

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  1 in total

1.  Possible Advantages of S53P4 Bioactive Glass in the Treatment of Septic Osteoarthritis of the First Metatarsophalangeal Joint in the Diabetic Foot.

Authors:  Matevž Kastrin; Vilma Urbančič Rovan; Igor Frangež
Journal:  J Clin Med       Date:  2021-03-15       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.